JCOGP
Journal of Controversies in Obstetrics & Gynecology and Pediatrics

As of January 2023, our "Journal of Controversies Obstetrics & Gynecology and Pediatrics" has been published under the Medihealth Academy to publish all articles, reviews and case reports on Pediatrics, especially in the field of Obstetrics and Gynecology. In order to facilitate the citation of the articles, to take our place in internationally respected indexes and to reach a wider readership, we will pay attention to the fact that our article language is only English in terms of acceptance.

eISSN: 2980-0579
Creative Commons CC BY-NC-ND 4.0 International License.
EndNote Style

Online Manuscript System

Index
Letter to the Editor
Hyperthermic intraperitoneal chemotherapy in gynecologic oncology: current evidence and national perspectives from Turkiye
Abstract
I am writing this letter because I have observed that publications on HIPEC in gynecologic oncology in our country are insufficient. The article in question is particularly important as it thoroughly addresses hyperthermic intraperitoneal chemotherapy (HIPEC), a method that is gaining increasing importance in the surgical treatment of gynecologic malignancies.

Keywords : Hyperthermic chemotherapy, gynecologic oncology, ovarian cancer

Download Article


1. Topgül K, Çetinkaya MB, Çiğdem Arslan N, et al. Cytoreductive surgery (SRC) and hyperthermic intraperitoneal chemotherapy (HIPEC) for treatment of peritoneal carcinomatosis: our initial experience and technical details. Turk J Surg. 2015;31(2):80-86. doi:10. 5152/UCD.2015.3034
2. Ayhan A, Yilmaz Baran S, Vatansever D, et al. Feasibility of hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer during COVID-19 pandemic.Int J Gynecol Cancer. 2021;31(6):883-887. doi:10.1136/ijgc-2021-002511
3. Ercan M, Aziret M, Karaman K, et al. Surgical and survival outcomes of cytoreductive surgery alone or with perioperative intraperitoneal chemotherapy in high peritoneal cancer index.Turk J Surg. 2024;40(3): 219-228. doi:10.47717/turkjsurg.2024.6457
4. van Driel WJ, Koole SN, Sikorska K, et al. Hyperthermic intraperitoneal chemotherapy in ovarian cancer.N Engl J Med. 2018;378(3):230-240. doi:10.1056/NEJMoa1708618
5. Classe JM, Meeus P, Hudry D, et al. Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (HIPEC) in first platinum-sensitive relapse of ovarian cancer (CHIPOR): a phase 3, open-label, randomized trial. Lancet Oncol. 2024;25(12):1551-1562. doi: 10.1016/S1470-2045(24)00336-0
Article available in :
Volume 3, Issue 4, 2025
Page : 100-101
https://doi.org/10.51271/JCOGP-0058
Article Information
Received : 08 Eki 2025
Accepted : 29 Eki 2025
Published : 30 Eki 2025
Corresponding Author :

İlyas Turan: Department of Gynecologic Oncology, Batman Training and Research Hospital, Batman, Turkiye

[email protected]
Citation : Turan İ. Hyperthermic intraperitoneal chemotherapy in gynecologic oncology: current evidence and national perspectives from Turkiye. J Controv Obstetr Gynecol Ped. 2025;3(4):100-101.

Read: 35
Download : 25
Cited: 0
_Footer